Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 538

1.

Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections.

Guilamet MCV, Bernauer M, Micek ST, Kollef MH.

Medicine (Baltimore). 2019 Apr;98(16):e15276. doi: 10.1097/MD.0000000000015276.

2.

Rebuttal From Drs Aguilar and Kollef.

Aguilar PR, Kollef MH.

Chest. 2019 Apr;155(4):668-669. doi: 10.1016/j.chest.2018.11.017. No abstract available.

PMID:
30955570
3.

POINT: Does Persistent or Worsening ARDS Refractory to Optimized Ventilation and Proning Deserve a Trial of Prostacyclin? Yes.

Aguilar PR, Kollef MH.

Chest. 2019 Apr;155(4):662-665. doi: 10.1016/j.chest.2018.11.018. No abstract available.

PMID:
30955568
4.

Reduction in antimicrobial use among medical intensive care unit patients during a cluster randomized crossover trial of palliative care consultation.

Burnham JP, Chi S, Ma J, Dans MC, Kollef MH.

Infect Control Hosp Epidemiol. 2019 Apr;40(4):491-492. doi: 10.1017/ice.2019.34. Epub 2019 Mar 6. No abstract available.

PMID:
30838966
5.

Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.

Blevins AM, Lashinsky JN, McCammon C, Kollef M, Micek S, Juang P.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02658-18. doi: 10.1128/AAC.02658-18. Print 2019 May.

PMID:
30782987
6.

Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials.

Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF.

Clin Infect Dis. 2019 Feb 4. doi: 10.1093/cid/ciz093. [Epub ahead of print]

PMID:
30722013
7.

Challenges in severe community-acquired pneumonia: a point-of-view review.

Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG.

Intensive Care Med. 2019 Feb;45(2):159-171. doi: 10.1007/s00134-019-05519-y. Epub 2019 Jan 31. Review.

PMID:
30706119
8.

Rationalizing antimicrobial therapy in the ICU: a narrative review.

Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodríguez-Baño J, Ruppé É, Salluh J, Taccone FS, Weiss E, Barbier F.

Intensive Care Med. 2019 Feb;45(2):172-189. doi: 10.1007/s00134-019-05520-5. Epub 2019 Jan 18. Review.

PMID:
30659311
9.

New antibiotics for community-acquired pneumonia.

Kollef MH, Betthauser KD.

Curr Opin Infect Dis. 2019 Apr;32(2):169-175. doi: 10.1097/QCO.0000000000000526.

PMID:
30640820
10.

Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia.

Cowley MC, Ritchie DJ, Hampton N, Kollef MH, Micek ST.

Chest. 2019 Jan;155(1):53-59. doi: 10.1016/j.chest.2018.10.014. Epub 2018 Oct 25.

PMID:
30621854
11.

Endotracheal intubation results in acute tracheal damage induced by mtDNA/TLR9/NF-κB activity.

Puyo CA, Earhart A, Staten N, Prince OA, Haug C, Kollef M, Awad M.

J Leukoc Biol. 2019 Mar;105(3):577-587. doi: 10.1002/JLB.5A0718-254RR. Epub 2018 Dec 13.

PMID:
30548974
12.

Antibiotic Thresholds for Sepsis and Septic Shock.

Kollef MH, Burnham JP.

Clin Infect Dis. 2018 Dec 7. doi: 10.1093/cid/ciy1035. [Epub ahead of print] No abstract available.

PMID:
30535353
13.

Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance.

Teshome BF, Vouri SM, Hampton N, Kollef MH, Micek ST.

Pharmacotherapy. 2019 Mar;39(3):261-270. doi: 10.1002/phar.2201. Epub 2019 Jan 7.

PMID:
30506852
14.

A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Falcone M, Russo A, Shindo Y, Farcomeni A, Pieralli F, Cangemi R, Liu J, Xia J, Okumura J, Sano M, Jones C, Vannucchi V, Mancone M, Micek S, Xu F, Violi F, Kollef M.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01556-18. doi: 10.1128/AAC.01556-18. Print 2019 Feb.

PMID:
30509940
15.

The carbon footprint of treating patients with septic shock in the intensive care unit.

McGain F, Burnham JP, Lau R, Aye L, Kollef MH, McAlister S.

Crit Care Resusc. 2018 Dec;20(4):304-312.

PMID:
30482138
16.

Re-estimating annual deaths due to multidrug-resistant organism infections.

Burnham JP, Olsen MA, Kollef MH.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):112-113. doi: 10.1017/ice.2018.304. Epub 2018 Nov 22. No abstract available.

PMID:
30463634
17.

Is Zero Ventilator-Associated Pneumonia Achievable?: Practical Approaches to Ventilator-Associated Pneumonia Prevention.

Vazquez Guillamet C, Kollef MH.

Clin Chest Med. 2018 Dec;39(4):809-822. doi: 10.1016/j.ccm.2018.08.004. Review.

PMID:
30390751
18.

Protocol for a multicentre, prospective cohort study of practice patterns and clinical outcomes associated with emergency department sedation for mechanically ventilated patients: the ED-SED Study.

Fuller BM, Mohr NM, Roberts BW, Carpenter CR, Kollef MH, Avidan MS.

BMJ Open. 2018 Oct 21;8(10):e023423. doi: 10.1136/bmjopen-2018-023423.

19.

Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection.

Burnham JP, Rojek RP, Kollef MH.

Medicine (Baltimore). 2018 Oct;97(42):e12782. doi: 10.1097/MD.0000000000012782.

20.

The most recent concepts for the management of bacterial and fungal infections in ICU.

Bassetti M, Poulakou G, Kollef MH.

Intensive Care Med. 2018 Nov;44(11):2000-2003. doi: 10.1007/s00134-018-5400-9. Epub 2018 Oct 6. No abstract available.

PMID:
30293148
21.

Postoperative Pneumonia Prevention in Pulmonary Resections: A Feasibility Pilot Study.

Semenkovich TR, Frederiksen C, Hudson JL, Subramanian M, Kollef MH, Patterson GA, Kreisel D, Meyers BF, Kozower BD, Puri V.

Ann Thorac Surg. 2019 Jan;107(1):262-270. doi: 10.1016/j.athoracsur.2018.08.008. Epub 2018 Oct 3.

PMID:
30291834
22.

Response.

Shorr AF, Kollef MH.

Chest. 2018 Jul;154(1):224. doi: 10.1016/j.chest.2018.02.028. No abstract available.

PMID:
30044736
23.

Diagnosis and Treatment of Acute Respiratory Distress Syndrome.

Fuller BM, Mohr NM, Kollef MH.

JAMA. 2018 Jul 17;320(3):305-306. doi: 10.1001/jama.2018.5928. No abstract available.

PMID:
30027241
24.

Prevention of hospital-acquired pneumonia.

Lyons PG, Kollef MH.

Curr Opin Crit Care. 2018 Oct;24(5):370-378. doi: 10.1097/MCC.0000000000000523.

PMID:
30015635
25.

Using wearable technology to predict health outcomes: a literature review.

Burnham JP, Lu C, Yaeger LH, Bailey TC, Kollef MH.

J Am Med Inform Assoc. 2018 Sep 1;25(9):1221-1227. doi: 10.1093/jamia/ocy082.

PMID:
29982520
26.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, François Timsit J, Welte T, Wunderink R.

ERJ Open Res. 2018 Jun 26;4(2). pii: 00028-2018. doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

27.

Differences in mortality between infections due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Burnham JP, Kwon JH, Olsen MA, Babcock HM, Kollef MH.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1138-1139. doi: 10.1017/ice.2018.142. Epub 2018 Jul 2. No abstract available.

PMID:
29961440
28.

The authors reply.

Roberts BW, Mohr NM, Ablordeppey E, Drewry AM, Ferguson IT, Trzeciak S, Kollef MH, Fuller BM.

Crit Care Med. 2018 Jul;46(7):e718-e719. doi: 10.1097/CCM.0000000000003110. No abstract available.

PMID:
29912116
29.

Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy.

Vazquez Guillamet C, Kollef MH.

Clin Infect Dis. 2018 Oct 15;67(9):1455-1462. doi: 10.1093/cid/ciy375.

PMID:
29741597
30.

Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST.

Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26.

PMID:
29706365
31.

Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e00198-18. doi: 10.1128/AAC.00198-18. Print 2018 Apr. No abstract available.

32.

Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections.

Burnham JP, Olsen MA, Stwalley D, Kwon JH, Babcock HM, Kollef MH.

Open Forum Infect Dis. 2018 Mar 15;5(3):ofy026. doi: 10.1093/ofid/ofy026. eCollection 2018 Mar.

33.

Erratum for Micek et al., "Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection".

Micek ST, Hampton N, Kollef M.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e00007-18. doi: 10.1128/AAC.00007-18. Print 2018 Mar. No abstract available.

34.

Frequent Versus Infrequent Monitoring of Endotracheal Tube Cuff Pressures.

Letvin A, Kremer P, Silver PC, Samih N, Reed-Watts P, Kollef MH.

Respir Care. 2018 May;63(5):495-501. doi: 10.4187/respcare.05926. Epub 2018 Jan 30.

35.

Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.

Britt NS, Ritchie DJ, Kollef MH, Burnham CA, Durkin MJ, Hampton NB, Micek ST.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02400-17. doi: 10.1128/AAC.02400-17. Print 2018 Apr.

36.

Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality.

Lyons PG, Micek ST, Hampton N, Kollef MH.

Crit Care Med. 2018 May;46(5):736-742. doi: 10.1097/CCM.0000000000002997.

PMID:
29373360
37.

Emergency department hyperoxia is associated with increased mortality in mechanically ventilated patients: a cohort study.

Page D, Ablordeppey E, Wessman BT, Mohr NM, Trzeciak S, Kollef MH, Roberts BW, Fuller BM.

Crit Care. 2018 Jan 18;22(1):9. doi: 10.1186/s13054-017-1926-4.

38.

Thirty-day hospital readmissions among mechanically ventilated emergency department patients.

Page DB, Drewry AM, Ablordeppey E, Mohr NM, Kollef MH, Fuller BM.

Emerg Med J. 2018 Apr;35(4):252-256. doi: 10.1136/emermed-2017-206651. Epub 2018 Jan 5.

PMID:
29305381
39.

Treatment of severe skin and soft tissue infections: a review.

Burnham JP, Kollef MH.

Curr Opin Infect Dis. 2018 Apr;31(2):113-119. doi: 10.1097/QCO.0000000000000431.

40.

The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure: An Underappreciated Issue.

Shorr AF, Fisher K, Micek ST, Kollef MH.

Chest. 2018 Jul;154(1):84-90. doi: 10.1016/j.chest.2017.12.005. Epub 2017 Dec 21.

PMID:
29274318
41.

Association Between Partial Pressure of Arterial Carbon Dioxide and Survival to Hospital Discharge Among Patients Diagnosed With Sepsis in the Emergency Department.

Roberts BW, Mohr NM, Ablordeppey E, Drewry AM, Ferguson IT, Trzeciak S, Kollef MH, Fuller BM.

Crit Care Med. 2018 Mar;46(3):e213-e220. doi: 10.1097/CCM.0000000000002918.

42.

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.

Torres A, Zhong N, Pachl J, Timsit JF, Kollef M, Chen Z, Song J, Taylor D, Laud PJ, Stone GG, Chow JW.

Lancet Infect Dis. 2018 Mar;18(3):285-295. doi: 10.1016/S1473-3099(17)30747-8. Epub 2017 Dec 16.

43.

Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.

Burnham JP, Kwon JH, Olsen MA, Babcock HM, Kollef MH.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):12-19. doi: 10.1017/ice.2017.254. Epub 2017 Dec 17.

44.

Monocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis.

Drewry AM, Ablordeppey EA, Murray ET, Dalton CM, Fuller BM, Kollef MH, Hotchkiss RS.

Shock. 2018 Oct;50(4):381-387. doi: 10.1097/SHK.0000000000001083.

PMID:
29240644
45.

Practice Patterns and Outcomes Associated With Early Sedation Depth in Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis.

Stephens RJ, Dettmer MR, Roberts BW, Ablordeppey E, Fowler SA, Kollef MH, Fuller BM.

Crit Care Med. 2018 Mar;46(3):471-479. doi: 10.1097/CCM.0000000000002885.

46.
47.

CAP, HCAP, HAP, VAP: The Diachronic Linguistics of Pneumonia.

Burnham JP, Kollef MH.

Chest. 2017 Nov;152(5):909-910. doi: 10.1016/j.chest.2017.05.002. No abstract available.

PMID:
29126531
48.

Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.

Micek ST, Hampton N, Kollef M.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01577-17. doi: 10.1128/AAC.01577-17. Print 2018 Jan. Erratum in: Antimicrob Agents Chemother. 2018 Feb 23;62(3):.

49.

Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.

Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, Berman C.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01323-17. doi: 10.1128/AAC.01323-17. Print 2018 Jan. Erratum in: Antimicrob Agents Chemother. 2018 Mar 27;62(4):.

50.

Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria.

Vazquez-Guillamet MC, Vazquez R, Micek ST, Kollef MH.

Clin Infect Dis. 2017 Oct 30;65(10):1607-1614. doi: 10.1093/cid/cix612.

PMID:
29020294

Supplemental Content

Loading ...
Support Center